BR112015028334A2 - agente e método para o tratamento de herpes - Google Patents
agente e método para o tratamento de herpesInfo
- Publication number
- BR112015028334A2 BR112015028334A2 BR112015028334A BR112015028334A BR112015028334A2 BR 112015028334 A2 BR112015028334 A2 BR 112015028334A2 BR 112015028334 A BR112015028334 A BR 112015028334A BR 112015028334 A BR112015028334 A BR 112015028334A BR 112015028334 A2 BR112015028334 A2 BR 112015028334A2
- Authority
- BR
- Brazil
- Prior art keywords
- agent
- treating herpes
- herpes
- treating
- methylpropanol
- Prior art date
Links
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 206010019973 Herpes virus infection Diseases 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000004584 polyacrylic acid Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13167597.7A EP2803354B1 (de) | 2013-05-14 | 2013-05-14 | Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen |
| PCT/EP2014/059813 WO2014184223A1 (de) | 2013-05-14 | 2014-05-14 | Mittel und verfahren zur behandlung von herpes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015028334A2 true BR112015028334A2 (pt) | 2017-07-25 |
Family
ID=48366229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015028334A BR112015028334A2 (pt) | 2013-05-14 | 2014-05-14 | agente e método para o tratamento de herpes |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160166603A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2803354B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2016518424A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2014267349A1 (cg-RX-API-DMAC10.html) |
| BR (1) | BR112015028334A2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2538335T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2014184223A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017212422A1 (en) * | 2016-06-08 | 2017-12-14 | Novartis Consumer Health Sa | Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions |
| US20210330700A1 (en) * | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols |
| DE102025101480A1 (de) | 2025-01-16 | 2026-07-16 | Pigmentsolution GmbH | Konservierungszusammensetzung |
| DE202026100173U1 (de) | 2025-01-16 | 2026-05-28 | Pigmentsolution GmbH | Rohr-im-Rohr-Homogenisierer |
| EP4778390A3 (de) | 2025-01-16 | 2026-08-12 | Pigmentsolution GmbH | Konservierungszusammensetzung |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2174242A (en) | 1937-08-13 | 1939-09-26 | Purdue Research Foundation | Aminoglycols |
| JPS6251617A (ja) * | 1985-08-30 | 1987-03-06 | Wako Pure Chem Ind Ltd | ビダラビンゲル軟膏 |
| JPS62263111A (ja) * | 1986-05-09 | 1987-11-16 | Shiseido Co Ltd | 粘性組成物 |
| US5075104A (en) * | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
| US5622690A (en) * | 1990-04-05 | 1997-04-22 | Nurture, Inc. | Seed-derived proteinaceous compositions for reduction of sunburn cell formation |
| JPH08143460A (ja) * | 1994-11-17 | 1996-06-04 | Haruhito Miyata | 水虫類の治療方法及び用材 |
| JPH11511180A (ja) * | 1996-06-12 | 1999-09-28 | ストア ソシエテ アノニマ | 化粧品のための物理的殺菌用ゲル |
| US7442369B1 (en) * | 2000-08-09 | 2008-10-28 | Mcneil Ab | Compositions of minoxidil |
| JPWO2004069261A1 (ja) * | 2003-02-03 | 2006-05-25 | アリジェン株式会社 | 抗ヘルペスウイルス外用製剤の製造方法 |
| JP2005263695A (ja) * | 2004-03-18 | 2005-09-29 | Suiko Giken Kk | 水虫治療薬 |
| US20060229364A1 (en) * | 2005-03-10 | 2006-10-12 | 3M Innovative Properties Company | Antiviral compositions and methods of use |
| US8267927B2 (en) * | 2007-01-24 | 2012-09-18 | Koninklijke Philips Electronics N.V. | Advanced ablation planning |
| WO2010127033A1 (en) * | 2009-04-28 | 2010-11-04 | Alltranz Inc. | Formulations of cannabidiol and methods of using the same |
| IT1395137B1 (it) * | 2009-08-05 | 2012-09-05 | Spider Biotech S R L | Nuovi peptidi antipatogeni |
| JP2011030981A (ja) * | 2009-08-06 | 2011-02-17 | Dainippon Printing Co Ltd | 皮膚貼付用組成物および皮膚貼付用材 |
| WO2012004669A1 (en) * | 2010-07-08 | 2012-01-12 | Devirex Ag | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| US20130072575A1 (en) * | 2011-09-19 | 2013-03-21 | Johnson & Johnson Consumer Companies, Inc. | Method and Composition for Treating Pain |
-
2013
- 2013-05-14 ES ES13167597.7T patent/ES2538335T3/es active Active
- 2013-05-14 EP EP13167597.7A patent/EP2803354B1/de not_active Not-in-force
-
2014
- 2014-05-14 AU AU2014267349A patent/AU2014267349A1/en not_active Abandoned
- 2014-05-14 US US14/891,102 patent/US20160166603A1/en not_active Abandoned
- 2014-05-14 BR BR112015028334A patent/BR112015028334A2/pt not_active Application Discontinuation
- 2014-05-14 WO PCT/EP2014/059813 patent/WO2014184223A1/de not_active Ceased
- 2014-05-14 JP JP2016513342A patent/JP2016518424A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2803354A1 (de) | 2014-11-19 |
| JP2016518424A (ja) | 2016-06-23 |
| WO2014184223A1 (de) | 2014-11-20 |
| ES2538335T3 (es) | 2015-06-19 |
| EP2803354B1 (de) | 2015-03-04 |
| US20160166603A1 (en) | 2016-06-16 |
| AU2014267349A1 (en) | 2015-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019008487A2 (es) | Compuesto de quinazolina | |
| PL3377637T3 (pl) | Kompozycje do stosowania w sposobach leczenia ran, zaburzeń i chorób skóry | |
| MX2017015938A (es) | Inhibidores de ezh2 para el tratar linfomas. | |
| MX378579B (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| BR112015026297A2 (pt) | terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer | |
| MY186311A (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| MX2017016134A (es) | Aril dihidro-2h-benzo[b][1,4]oxazina sulfonamida y compuestos relacionados para uso como agonistas de rory y el tratamiento de enfermedad. | |
| ZA201801300B (en) | Composition and medical device comprising acetylsalicylic acid for the treatment of human papilloma virus skin infections | |
| WO2016191458A3 (en) | Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment | |
| WO2016040169A3 (en) | Mucolytic agents for use in tretaing pulmonary sarcoidosis | |
| PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
| HK1218251A1 (zh) | 用拉喹莫德治疗多发性硬化症 | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
| BR112016029996A2 (pt) | utilização cosmética, composição e método cosmético para tratar os odores corporais | |
| JOP20190056B1 (ar) | مركبات للاستخدام في علاج القصور الكلوي الحاد | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| MX2018002681A (es) | Agente mejorador de la inmunidad contra el cancer por el antagonista de "allergin-1". | |
| WO2015063613A3 (en) | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents | |
| BR112015022025A8 (pt) | composição e uso de um agente ativo | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| EA201792085A1 (ru) | Смешанные дисульфидные конъюгаты тиенопиридиновых соединений и их применение | |
| AR103636A1 (es) | Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol | |
| SG10201903630UA (en) | Iminosugars useful for the treatment of viral diseases | |
| UA106472U (uk) | Засіб для лікування дерматологічних захворювань |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |